Global Psychedelic Drugs Market to Reach US$6,330 Mn by 2026 as Clinical Trials Show Promising Outcomes, Finds Fairfield Market Research

LONDON, Sept. 13, 2021 /PRNewswire/ — A phenomenal rise of mental health issues coupled with an unmet need for treatment is fuelling demand for psychedelic drugs. According to a study conducted by Harvard, the global cost of mental health is expected to…

Click here to view the original article.